Regulatory Updates
🇺🇸 FDA Page 27FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.
Showing 313–324 of 373 articles
NICE Approval for Imfinzi: Implications for Stomach Cancer Treatment
US Cancer Clinics Rush for Revolution Medicines' New Pancreatic Cancer Drug
Makary Resigns as FDA Commissioner: Implications for Drug Approvals
Holland & Knight Health Dose: Oncology Updates from May 12, 2026
Four FDA Actions Reshaping Drug Development in 2026
FDA Blocks Melanoma Drug Amid Confusion Under Makary Leadership
Amgen Inc Stock: Lung Cancer Setback Meets Steady Cash Flow
FDA Grants Dual Approval for T-DXd in HER2+ Early Breast Cancer
FDA Roundup: Oncology Drug Approvals in 2026
6 Biotechs That Could Be Big Pharma’s Next M&A Target
FDA Policy Tracker 2026: Psychedelics Regulatory Updates
NICE Backs Imfinzi for Stomach Cancer: Implications for Investors